Syndrome de Li-Fraumeni : Questions médicales fréquentes
Nom anglais: Li-Fraumeni Syndrome
Descriptor UI:D016864
Tree Number:C18.452.284.520
Termes MeSH sélectionnés :
Data Management
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Li-Fraumeni : Questions médicales les plus fréquentes",
"headline": "Syndrome de Li-Fraumeni : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Li-Fraumeni : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-23",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Li-Fraumeni"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles dus à un défaut de réparation de l'ADN",
"url": "https://questionsmedicales.fr/mesh/D049914",
"about": {
"@type": "MedicalCondition",
"name": "Troubles dus à un défaut de réparation de l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D049914",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.284"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Li-Fraumeni",
"alternateName": "Li-Fraumeni Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D016864",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Payal P Khincha",
"url": "https://questionsmedicales.fr/author/Payal%20P%20Khincha",
"affiliation": {
"@type": "Organization",
"name": "Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland."
}
},
{
"@type": "Person",
"name": "David Malkin",
"url": "https://questionsmedicales.fr/author/David%20Malkin",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, and Department of Pediatrics, University of Toronto, Toronto, Ontario."
}
},
{
"@type": "Person",
"name": "Sharon A Savage",
"url": "https://questionsmedicales.fr/author/Sharon%20A%20Savage",
"affiliation": {
"@type": "Organization",
"name": "Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland."
}
},
{
"@type": "Person",
"name": "Allison Werner-Lin",
"url": "https://questionsmedicales.fr/author/Allison%20Werner-Lin",
"affiliation": {
"@type": "Organization",
"name": "School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA."
}
},
{
"@type": "Person",
"name": "Maria Isabel Achatz",
"url": "https://questionsmedicales.fr/author/Maria%20Isabel%20Achatz",
"affiliation": {
"@type": "Organization",
"name": "Centro de Oncologia, Hospital Sirio-Libanes, Rua Dona Adma Jafet, 115 - Bela Vista, São Paulo, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The genotype list string code syntax for exchanging nomenclature-level genotyping results in clinical and research data management and analysis systems.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37403548",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/tan.15145"
}
},
{
"@type": "ScholarlyArticle",
"name": "PMTCT Data Management and Reporting during the Transition Phase of Implementing the Rationalised Registers in Amathole District, Eastern Cape Province, South Africa.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36497931",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph192315855"
}
},
{
"@type": "ScholarlyArticle",
"name": "EnzymeML: seamless data flow and modeling of enzymatic data.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36759590",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41592-022-01763-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enabling data sharing and utilization for African population health data using OHDSI tools with an OMOP-common data model.",
"datePublished": "2023-06-09",
"url": "https://questionsmedicales.fr/article/37361151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1116682"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health data hubs: an analysis of existing data governance features for research.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37430347",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12961-023-01026-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles dus à un défaut de réparation de l'ADN",
"item": "https://questionsmedicales.fr/mesh/D049914"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome de Li-Fraumeni",
"item": "https://questionsmedicales.fr/mesh/D016864"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Li-Fraumeni - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Li-Fraumeni",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Li-Fraumeni",
"description": "Comment est diagnostiqué le syndrome de Li-Fraumeni ?\nQuels tests génétiques sont utilisés ?\nQuels critères cliniques sont utilisés pour le diagnostic ?\nLe diagnostic peut-il être posé à tout âge ?\nLes tests de dépistage sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Data+Management&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Li-Fraumeni",
"description": "Quels sont les symptômes du syndrome de Li-Fraumeni ?\nLes symptômes apparaissent-ils à un âge précoce ?\nY a-t-il des signes spécifiques à surveiller ?\nLes symptômes sont-ils toujours liés à des cancers ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Data+Management&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Li-Fraumeni",
"description": "Comment prévenir le syndrome de Li-Fraumeni ?\nLes personnes à risque doivent-elles se faire dépister ?\nY a-t-il des recommandations pour les familles touchées ?\nLes habitudes de vie peuvent-elles influencer le risque ?\nLes tests génétiques sont-ils recommandés pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Data+Management&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Li-Fraumeni",
"description": "Quels traitements sont disponibles pour ce syndrome ?\nLa prévention des cancers est-elle possible ?\nLes traitements sont-ils différents selon le cancer ?\nY a-t-il des traitements expérimentaux disponibles ?\nLe suivi post-traitement est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Data+Management&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Li-Fraumeni",
"description": "Quelles complications peuvent survenir avec ce syndrome ?\nLes complications sont-elles prévisibles ?\nComment gérer les complications psychologiques ?\nLes complications peuvent-elles affecter la qualité de vie ?\nY a-t-il des complications spécifiques aux traitements ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Data+Management&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Li-Fraumeni",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il le risque ?\nLes femmes sont-elles plus à risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux sont-ils impliqués ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Data+Management&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment est diagnostiqué le syndrome de Li-Fraumeni ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique familial et des tests génétiques pour identifier des mutations."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ciblent principalement les gènes TP53 et d'autres gènes associés au cancer."
}
},
{
"@type": "Question",
"name": "Quels critères cliniques sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents familiaux de cancers précoces et multiples."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être posé à tout âge ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diagnostic peut être établi à tout âge, souvent après l'apparition de cancers."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils recommandés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un dépistage régulier est conseillé pour détecter précocement les cancers."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du syndrome de Li-Fraumeni ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le type de cancer, incluant des douleurs, des masses et des changements de poids."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge précoce ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cancers associés apparaissent souvent chez les jeunes adultes ou même les enfants."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les douleurs persistantes, les changements cutanés et les anomalies mammaires."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours liés à des cancers ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais tout symptôme persistant doit être évalué par un professionnel."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier en fonction des cancers développés."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome de Li-Fraumeni ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention, mais un dépistage régulier peut aider à détecter les cancers tôt."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles se faire dépister ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque élevé doivent suivre un programme de dépistage régulier."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les familles touchées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les familles doivent consulter des conseillers en génétique pour des recommandations personnalisées."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles influencer le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain peut réduire le risque de certains cancers, mais pas tous."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils recommandés pour tous ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils sont recommandés principalement pour les personnes ayant des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ce syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie selon le cancer."
}
},
{
"@type": "Question",
"name": "La prévention des cancers est-elle possible ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et des interventions précoces peuvent aider à prévenir certains cancers."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents selon le cancer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de cancer peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des essais cliniques peuvent offrir des options de traitement innovantes pour les patients."
}
},
{
"@type": "Question",
"name": "Le suivi post-traitement est-il important ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est crucial pour détecter toute récidive ou nouveaux cancers."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ce syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des cancers multiples, des effets secondaires des traitements et des problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées, mais d'autres peuvent survenir de manière inattendue."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications psychologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un soutien psychologique et des groupes de soutien peuvent aider à gérer l'anxiété et la dépression."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications liées aux traitements et aux cancers peuvent altérer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques aux traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires comme la fatigue, la nausée et l'immunosuppression."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de cancers et les mutations génétiques, notamment TP53, sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme le tabagisme et l'alimentation peuvent influencer le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le syndrome affecte également les hommes, bien que certains cancers soient plus fréquents chez les femmes."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de développer des cancers augmente avec l'âge, surtout après 30 ans."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils impliqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux peuvent contribuer au risque, mais le syndrome est principalement génétique."
}
}
]
}
]
}
The nomenclatures used to describe HLA and killer-cell immunoglobulin-like receptor (KIR) alleles distinguish unique nucleotide and peptide sequences, and patterns of expression, but are insufficient ...
The National Department of Health, in March 2015, launched the implementation of Rationalisation of Register, aimed at reducing the amount of time invested in completing the registers and collecting d...
This study explored the effect of the rollout of Rationalisation of Register on the documentation and reporting of Prevention of Mother-to-Child Transmission (PMTCT) programme data with the existing s...
A mixed-method research approach was used, and three source documents, namely: Tally sheet, Antenatal care (ANC) register, and Tick register used for collecting and reporting PMTCT data, were reviewed...
All selected facilities completed the three source documents. The facilities consolidated their PMTCT data monthly before reporting to the District Health Information System (DHIS). Less than half of ...
PMTCT data management and reporting were challenging during the transitioning phase of implementing the rationalised registers because of different timelines instituted in the facilities and non-avail...
The design of biocatalytic reaction systems is highly complex owing to the dependency of the estimated kinetic parameters on the enzyme, the reaction conditions, and the modeling method. Consequently,...
The COVID-19 pandemic has spurred the use of AI and DS innovations in data collection and aggregation. Extensive data on many aspects of the COVID-19 has been collected and used to optimize public hea...
Digital transformation in healthcare and the growth of health data generation and collection are important challenges for the secondary use of healthcare records in the health research field. Likewise...
To capture the different data governance behind health data hubs across Europe, a survey focused on analysing the feasibility of linking individual-level data between data collections and the generati...
In total, 41 survey responses received until June 2022 were analysed. Stratification methods were performed to cover the different levels of granularity identified in some data hubs' characteristics. ...
The analysis of the responses from health data hub respondents across Europe provided a list of the most frequent aspects, which concluded with a set of specific best practices on data management and ...
Previous research has shown that while missing data are common in bioarchaeological studies, they are seldom handled using statistically rigorous methods. The primary objective of this article is to e...
Missing data were simulated on complete datasets of ordinal (n = 287) and continuous (n = 369) bioarchaeological data. Missing values were imputed using five imputation methods (mean, predictive mean ...
In all instances, listwise deletion was least successful at approximating the original parameters. Imputation of continuous data was more effective than ordinal data. Overall, no one method performed ...
These findings support the use of imputation methods over deletion for handling missing bioarchaeological and paleopathology data, especially when the data are continuous. Whereas deletion methods red...
We investigated the association between various food groups and obesity in Japanese patients with type 2 diabetes....
2070 patients with type 2 diabetes who attended 26 diabetes clinics throughout Japan were analyzed and were divided into obese and non-obese groups. Intakes of food groups determined by a food frequen...
Non-obese patients consumed a larger variety of food groups than obese patients, with the diets of non-obese individuals closer to the traditional Japanese diet characterized by fish, seaweed, and soy...
Food groups and their combinations that were strongly associated with obesity in Japanese patients with type 2 diabetes were identified. Our findings also suggested an inverse association between the ...
The adoption of new technologies in clinical care systems has propitiated the availability of a great amount of valuable data. However, this data is usually heterogeneous, requiring its harmonization ...
The framework includes an ontology-based common data model (i.e. SCDM), a data transformation pipeline and a semantic query system. Heterogeneous datasets, mapped to different terminologies, are integ...
Several datasets from different European institutions have been integrated by using the framework in the context of the European H2020 Precise4Q project. Through the query system, data scientists were...
The flexible data representation using RDF, together with the formal semantic underpinning provided by the SCDM, have enabled the semantic integration, query and advanced exploitation of heterogeneous...
The German initiative "National Research Data Infrastructure for Personal Health Data" (NFDI4Health) focuses on research data management in health research. It aims to foster and develop harmonized in...
Telecommunication (telco) cloud services have emerged as crucial components in the modern digital landscape, offering extensive capabilities for data management, connectivity, and service provision. H...